“…The clinical progression usually involves rapid enlargement of the affected area without skin ulceration (Homler et al, 1986;Lee et al, 2001;Calka, 2002;Gutierrez and Rodriguez, 2007). CE is most commonly caused by breast carcinoma, but it has also been related to other malignancies; thyroid, bladder, lung, gastric (Homler et al, 1986;Lever, 1991;Lookingbill, 1993;Wnamaker et al, 1993;Schwartz, 1995;Nambi and Tharakaram, 1999;Hamamoto et al, 2001;Calka, 2002;Gutierrez and Rodriguez, 2007). Cutaneous metastases occur in 1% to 5% of patients with visceral malignancies (Hamamoto et al, 2001;Lookingbill, 1993), Between 10% and 35% of women with operable breast cancer will experience an isolated locoregional recurrence following their primary treatment.…”